SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (1972)9/29/2000 6:22:34 PM
From: scaram(o)ucheRead Replies (1) of 4974
 
Damn, sure is hard to get any rest in retirement. This will change the nature of this beast........

Friday September 29, 5:47 pm Eastern Time

Press Release

SOURCE: OSI Pharmaceuticals, Inc.

OSI Pharmaceuticals Announces a Public Offering

UNIONDALE, N.Y., Sept. 29 /PRNewswire/ -- OSI Pharmaceuticals, Inc. (Nasdaq:
OSIP - news) announced today that it has filed a registration statement with the Securities and Exchange Commission relating
to a proposed public offering of 4.5 million shares of its common stock. The Company also granted the underwriters an option
to purchase up to 675,000 shares to cover over-allotments, if any. An underwriting group consisting of Robertson Stephens,
Inc., Lehman Brothers Inc., Prudential Vector Healthcare Group, a unit of Prudential Securities, Lazard Freres & Co. LLC
and Adams, Harkness & Hill, Inc. will offer the shares. Robertson Stephens, Inc. and Lehman Brothers Inc., will function as
joint book-running managers for the offering. (snip)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext